Cite
HARVARD Citation
Johne, A. et al. (n.d.). 369 Open-label, single center, phase I trial to investigate the mass balance and absolute bioavailability of the oral c-Met inhibitor tepotinib. European journal of cancer. pp. S77-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Johne, A. et al. (n.d.). 369 Open-label, single center, phase I trial to investigate the mass balance and absolute bioavailability of the oral c-Met inhibitor tepotinib. European journal of cancer. pp. S77-. [Online].